Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kelly Hoye
Observed name:
Kelly T. Hoye
Institution:
University of North Carolina at Chapel Hill
Observed institutions:
University of North Carolina at Chapel Hill,
University of Miami,
Washington University in St. Louis,
Sylvester Comprehensive Cancer Center,
UNC Lineberger Comprehensive Cancer Center,
University of Pennsylvania
show all 6
OpenAlex ID:
A5036123793
Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
2015
·
Travis J. Yates
, Luis E. Lopez
, et al.
·
JNCI Journal of the National Cancer Institute
·
86
Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2016
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
·
Clinical Cancer Research
·
66
Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
2016
·
Vaishali Kapoor
, David Y.A. Dadey
, et al.
·
Journal of Nuclear Medicine
·
27
PDF
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
2020
·
Vinata B. Lokeshwar
, Daley S. Morera
, et al.
·
Clinical Cancer Research
·
19
Phase 1 Trial of CD30-Directed, CCR4 Co-Expressing Chimeric Antigen Receptor T-Cells in Patients with CD30+ Cutaneous T-Cell Lymphomas Refractory to Brentuximab Vedotin
2024
·
Daniel K Reef
, Catherine Joyce Arago Cheng
, et al.
·
Blood
·
8
PDF
CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma
2024
·
Natalie Grover
, Dominic Moore
, et al.
·
Blood
·
6
PDF
A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas
2022
·
Christopher Dittus
, Roy Ervin Strowd III
, et al.
·
Blood
·
2
Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone ( BV ‐ CHEP ) for the treatment of aggressive adult T‐cell leukaemia/lymphoma
2025
·
Christopher Dittus
, Matthew J. Weinstock
, et al.
·
British Journal of Haematology
·
1
PDF
Abstract 4599: Antibody targeting PDZ domain of TIP-1 induces proliferation arrest through AKT/mTOR signaling inhibition in lung cancer and glioblastoma
2017
·
Vaishali Kapoor
, David Dadey
, et al.
·
Cancer Research
·
1
Supplementary figure legend from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Supplementary Figure 1 from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Supplementary Tables and Figures from A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
2023
·
Vinata B. Lokeshwar
, Daley S. Morera
, et al.
Data from A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
2023
·
Vinata B. Lokeshwar
, Daley S. Morera
, et al.
Data from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Data from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Data from A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
2023
·
Vinata B. Lokeshwar
, Daley S. Morera
, et al.
Supplementary Tables and Figures from A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
2023
·
Vinata B. Lokeshwar
, Daley S. Morera
, et al.
Supplementary figure legend from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Supplementary Figure 1 from Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models
2023
·
David Y.A. Dadey
, Vaishali Kapoor
, et al.
Abstract 5615: Antibodies targeting TIP1 enhance the efficacy of radiotherapy in lung cancer and glioblastoma
2018
·
Vaishali Kapoor
, Abhay K. Singh
, et al.
·
Cancer Research
Abstract 2681: 4-methylumbelliferone: Dietary supplement turned chemo-preventive and anti-metastatic agent for prostate cancer
2014
·
Travis Yates
, David Alonzo
, et al.
·
Cancer Research
Abstract 1033: Inhibiting bladder cancer metastasis with a dietary supplement
2014
·
Kelly T. Hoye
, Travis Yates
, et al.
·
Cancer Research
Mp21-14 Utilizing Dietary Supplements to Target Biomarkers of Bladder Cancer Metastasis
2014
·
David Alonzo
, Travis Yates
, et al.
·
The Journal of Urology
Mp28-15 Hyal4: a New Hyaluronidase Associated With Bladder Cancer Diagnosis and Prognosis
2014
·
John Shields
, Soum Lokeshwar
, et al.
·
The Journal of Urology
The Effect of Tobacco Smoke Toxicants on Hyaluronic Acid Family Biomarkers of Urothelial Neoplasms
2014
·
Kelly Hoye
Show more works
View as search
Works count:
25
Citation count:
216
H-index:
6
I10-index:
4
Year
Topic
Type